CC-5013
| CC-5013 | |
|---|---|
| Term | CC-5013 |
| Short definition | CC-5013 - A drug similar to thalidomide used alone or with other drugs to treat adults with certain types of follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, multiple myeloma, or anemia caused by certain types of myelodysplastic syndromes. It is also being studied in the treatment of other diseases and cancers. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
CC-5013 - A drug similar to thalidomide used alone or with other drugs to treat adults with certain types of follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, multiple myeloma, or anemia caused by certain types of myelodysplastic syndromes. It is also being studied in the treatment of other diseases and cancers. CC-5013 can help the immune system kill abnormal blood cells or cancer cells. It can also prevent the growth of new blood vessels that tumors need to grow. CC-5013 is a type of anti-angiogenesis agent and a type of immunomodulating agent. Also called lenalidomide and Revlimid
External links
- Medical encyclopedia article on CC-5013
- Wikipedia's article - CC-5013
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski